The Latest Breaking News from JNJ

Multi-decade high inflation, combined with the prospect of strong central bank interest rate hikes this year, might trigger a recession. So, investors seeking to beat the consequent market downturn might consider investing in fundamentally-sound stocks Johnson & Johnson (JNJ), Walmart (WMT), and Coca-Cola (KO), given the inelastic demands for their…

Warren Buffett’s long-term value investing strategy serves as a guide for investors to ensure high returns. With the market volatility becoming more severe after the Fed’s recent interest rate hike, Buffett’s top holdings could be ideal investments for long-term investors. To that end, buying and holding Johnson & Johnson (JNJ)…

As the Fed raised benchmark interest rates by another 75 basis points to fight inflation, growth projections have dimmed down. With market conditions remaining uncertain, fundamentally strong stocks Johnson & Johnson (JNJ), Oracle Corporation (ORCL), and Kroger Co. (KR) might be solid buys to cushion your portfolio. Read more.

In line with most expectations, the Fed went ahead with its third consecutive 75 bps interest rate hike. With the Fed more than willing to risk recession with further aggressive rate hikes to bring inflation under control, it would be wise to invest in resilient stocks UnitedHealth (UNH), Johnson &…

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

August CPI figures indicate that inflation is yet to be controlled, and the Fed might launch another significant interest rate hike next week. As recessionary fears loom over the economy, it might be ideal for seniors to invest in the fundamentally sound stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and…

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

The stock market has witnessed significant volatility on worries over a slowing economy amid high inflation and the Fed’s hawkish stance to tame it. As these factors are expected to keep the market under pressure in the near term, it could be wise to invest in fundamentally strong dividend-paying stocks…

Recession odds are rising due to the onslaught of aggressive rate hikes by the Fed. Healthcare is conventionally considered a defensive sector. Hence, we think Johnson & Johnson (JNJ), AbbVie (ABBV), and Bristol-Myers Squibb (BMY) might be solid buys now. Read on….